Brief: Targovax Gets FDA Authorization To Initiate Clinical Trials In USA
June 23 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX ANNOUNCES THAT THE FDA HAS GRANTED AUTHORIZATION
TO
INITIATE
* TARGOVAX ANNOUNCES THAT FDA HAS GRANTED AUTHORIZATION TO
INITIATE CLINICAL TRIALS WITH ENHANCED TG01 RAS VACCINE IN USA
Source text for Eikon: ID:nObiy4LYCa
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration